At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 302 enrolled
Drug / intervention
TOF-Watch SX® Monitoring of NMBdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Residual Curarization and Its Incidence at Tracheal Extubation
In Brief
A Phase 4 clinical trial evaluating TOF-Watch SX® Monitoring of NMB for Observation of Neuromuscular Block. Completed, enrolled 302 participants.
Detailed Summary
This study will assess the residual neuromuscular blockade (NMB) Train-Of-Four (TOF) ratios at tracheal extubation when anesthesiologists have determined that full recovery of neuromuscular function has occurred using standard clinical criteria for participants whose non-depolarizing-induced NMB is either not reversed or reversed with an acetylcholinesterase inhibitor administered as per standard routine care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObservation of Neuromuscular Block
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMar 2011
Enrollment StartJun 2011
Primary CompletionMay 2012
TodayJul 2026
First PostedMar 18, 2011
Enrollment StartJun 1, 2011
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 15.3 years ago
Interventions
TOF-Watch SX® Monitoring of NMBdevice
Participants will have the extent of NMB monitored by a TOF-Watch SX®.